CHORUS: A Clinical Study of Sotatercept (MK-7962) in People With Combined Postcapillary and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (MK-7962-041) (clinicaltrials.gov) - Sep 25, 2026 - P3 | N=352 | Not yet recruiting | Sponsor: Merck Sharp & Dohme LLC
New P3 trial • Cardiovascular • Congestive Heart Failure • Heart Failure • Hypertension • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases
|